300858.SZ · 科拓生物
China A-shares · RS rating 45 · As of 2026-10-14
| Price | 14.19 CNY |
|---|---|
| 1-day change | -1.9% |
| RS rating (overall / 1M / 3M / 12M) | 45 / 59 / 52 / 40 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 9 / 14 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.6% |
| Distance from 52-week high | +44.2% |
| Market cap (USD) | $579.3M |